Interaction between CD44 and hyaluronic acid regulates human prostate cancer development

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• CD44 is a cell surface glycoprotein involved in cell-cell and cell-extracellular matrix interactions.
• Hyaluronic acid (HA) is a major component of the extracellular matrix, implicated in various biological processes including cancer progression.
• The role of CD44 standard isoform (CD44s) and its interaction with HA in prostate cancer development requires further elucidation.

Purpose of the Study:

• To investigate the functional significance of the interaction between CD44 standard (CD44s) and hyaluronic acid (HA) in the context of human prostate cancer.
• To determine the impact of CD44s reintroduction on prostate cancer cell behavior, including adhesion, migration, and growth.
• To evaluate the in vivo effects of CD44s expression on tumor development and metastatic potential.

Main Methods:

• Transfection of CD44s cDNA into PC3 prostate cancer cells, which exhibit low endogenous CD44s expression.
• Assessment of cell adhesion and migration capabilities towards HA using in vitro assays.
• Measurement of in vitro cell growth rates via MTT assay.
• Evaluation of in vivo tumor development and metastasis in athymic nude mice using subcutaneous, intravenous, and intraperitoneal injection models.

Main Results:

• Reintroduction of CD44s significantly enhanced PC3 cell binding and migration specifically to HA.
• In vitro proliferation of CD44s-transfected PC3 cells was notably decreased.
• CD44s-expressing PC3 cells exhibited reduced tumorigenicity and metastatic potential in vivo.

Conclusions:

• Downregulation of CD44s is a significant factor in human prostate cancer development.
• The reduced ability to bind HA, associated with CD44s downregulation, contributes to prostate cancer progression.
• Targeting the CD44s-HA interaction may offer therapeutic strategies for prostate cancer.